Cargando…

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder

Attention-deficit hyperactivity disorder is a frequent condition in children and often extends into adulthood. Use of immediate-release methylphenidate (MPH) has raised concerns about potential cardiovascular adverse effects within a few hours after administration. This study was carried out to inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamberti, Marco, Italiano, Domenico, Guerriero, Laura, D’Amico, Gessica, Siracusano, Rosamaria, Ingrassia, Massimo, Germanò, Eva, Calabrò, Maria Pia, Spina, Edoardo, Gagliano, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431494/ https://www.ncbi.nlm.nih.gov/pubmed/26056451 http://dx.doi.org/10.2147/NDT.S79866

Ejemplares similares

Autistic Traits and Empathy in Children With Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder and Co-occurring Attention Deficit Hyperactivity Disorder/Autism Spectrum Disorder
por: Aiello, Stefania, et al.
Publicado: (2021)

Can Attention Deficits Predict a Genotype? Isolate Attention Difficulties in a Boy with Klinefelter Syndrome Effectively Treated with Methylphenidate
por: Gagliano, Antonella, et al.
Publicado: (2014)

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2013)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2015)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
por: Biederman, Joseph, et al.
Publicado: (2007)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
por: Pereira Ribeiro, Johanne, et al.
Publicado: (2021)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
por: Hodgkins, Paul, et al.
Publicado: (2012)

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy: Profile Report
por: Keating, Gillian M.
Publicado: (2012)

Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder
por: Arabgol, Fariba, et al.
Publicado: (2015)

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
por: Golubchik, Pavel, et al.
Publicado: (2014)

The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017)

The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children
por: Panahandeh, Gholamreza, et al.
Publicado: (2017)

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017)

Methylphenidate and the risk of burn injury among children with attention-deficit/hyperactivity disorder
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2020)

Association Between Tic Aggravation and Methylphenidate in Youth With Attention-Deficit/Hyperactivity Disorder
por: Cha, Jung Yoon, et al.
Publicado: (2021)

Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children Treated with Methylphenidate
por: Tohidi, Sepehr, et al.
Publicado: (2021)

Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder
por: Pasha, Khadija, et al.
Publicado: (2023)

The effect of methylphenidate on pain perception thresholds in children with attention deficit hyperactivity disorder
por: Bozkurt, Abdullah, et al.
Publicado: (2023)

Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder
por: Cao, Ai-hua, et al.
Publicado: (2012)

Does Methylphenidate Cause a Cytogenetic Effect in Children with Attention Deficit Hyperactivity Disorder?
por: Walitza, Susanne, et al.
Publicado: (2007)

Methylphenidate Normalizes Frontocingulate Underactivation During Error Processing in Attention-Deficit/Hyperactivity Disorder
por: Rubia, Katya, et al.
Publicado: (2011)

The Effectiveness of Methylphenidate in the Treatment of Encopresis Independent from Attention-Deficit Hyperactivity Disorder Symptoms
por: Akça, Ömer Faruk, et al.
Publicado: (2015)

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder
por: Boesen, Kim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ub6p6hsmn0a5cr42r9t7nnnjag